+1 (321) 355-2686
6 STRATEGIES FOR OPTIMIZING CROSS-FUNCTIONAL COLLABORATION BETWEEN COMPLIANCE AND ACCESS
A defining characteristic of successful patient support programs is the level of cross-functional collaboration.
As the affordability landscape continues to evolve, barriers for patients to access medication continue to become more complex. As a result, manufacturers have come together to collaborate on how to further access to care, understand changes in health policy, and optimize support for better patient outcomes.
For this whitepaper, Justine Hughes aligned with four industry compliance and patient services experts on the strategies pharmaceutical companies can use to promote collaboration.
Participants included:
​
-
Laurie Hughes, Head of U.S. Patient Services, Biogen
-
Rahul Khara, PharmD, Vice President, Legal and Chief Compliance Officer, Acceleron Pharma Inc.
-
Terence Milton, JD, Director, Ethics & Compliance, Managed Healthcare Services and Consumer Experience, Eli Lilly and Company
-
Michael Sanders, Market Access Strategy Lead, Orphan and Rare Disease, UCB
Register to Read the Whitepaper